跳至主要内容
临床试验/ACTRN12622000920796
ACTRN12622000920796招募中2 期

A prospective randomised, double-blind, placebo-controlled pilot study of the effect of ketamine for adjunct analgesia therapy on opioid requirements in adult mechanically ventilated patients

Austin Health0 个研究点目标入组 125 人开始时间: 2022年6月28日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
Austin Health
入组人数
125

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 79 Years(—)
性别
All

入选标准

  • Equal to or greater than 18 years of age
  • Mechanically ventilated at the time of assessment for eligibility
  • Opioid medication infusion prescribed by treating intensive care unit physician
  • Enrolment to occur within the first 12 hours of intensive care unit admission

排除标准

  • Cardiac surgical patients
  • Previous adverse reaction to ketamine
  • Equal to or older than 80 years of age
  • Pregnancy or lactation
  • Uncontrolled hypertension defined as systolic blood pressure of greater than 180 millimeters of mercury
  • Uncontrolled heart failure
  • Patients admitted to intensive care for end-of-life care or to facilitate organ donation
  • Previous enrolment in the KALME trial
  • No legal surrogate identified or able to provide informed consent to continue for patient

研究者

发起方
Austin Health

相似试验

已完成
不适用
A prospective randomised, double-blind, placebo controlled trial to assess the respiratory effects of buprenorphine versus morphine in anaethetised patientsSurgery: AnaesthesiaSurgeryAnaesthesia
ISRCTN41174967Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)90
已完成
不适用
A prospective, randomised, double-blind placebo-controlled trial of effects of glyceryl trinitrate ointment on the pain experiences during transdermal ultrasound guided biopsy of the prostaterological and Genital Diseases: Prostate biopsyUrological and Genital DiseasesProstate biopsy
ISRCTN66668243Department of Health (UK)100
进行中(未招募)
1 期
A phase III placebo-controlled efficacy and safety study of mocravimod as an adjunctive and maintenance treatment in AML patients undergoing allo-HCT (MO-TRANS Study)Adjunctive and maintenance treatment to HCTMedDRA version: 21.0Level: LLTClassification code 10000886Term: Acute myeloid leukemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2021-002864-36-DEPriothera S.A.S.249
招募中
3 期
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCTAacute myeloid leukemia (AML)
JPRN-jRCT2011230008Kueenburg Elisabeth30
进行中(未招募)
1 期
A phase IIb placebo-controlled efficacy and safety study of mocravimod as an adjunctive and maintenance treatment in AML patients undergoing allo-HSCT (MO-TRANS Study)Adjunctive and maintenance treatment to HSCTMedDRA version: 21.0Level: LLTClassification code 10000886Term: Acute myeloid leukemiaSystem Organ Class: 100000004864
EUCTR2021-002864-36-ESPriothera S.A.S.249